These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 16569807)

  • 1. Depressive symptoms in coronary artery disease patients after hypertension treatment.
    Ried LD; Tueth MJ; Taylor MD; Sauer BC; Lopez LM; Pepine CJ
    Ann Pharmacother; 2006 Apr; 40(4):597-604. PubMed ID: 16569807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Study of Antihypertensive Drugs and Depressive Symptoms (SADD-Sx) in patients treated with a calcium antagonist versus an atenolol hypertension Treatment Strategy in the International Verapamil SR-Trandolapril Study (INVEST).
    Ried LD; Tueth MJ; Handberg E; Kupfer S; Pepine CJ;
    Psychosom Med; 2005; 67(3):398-406. PubMed ID: 15911902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood pressure control and cardiovascular outcomes in high-risk Hispanic patients--findings from the International Verapamil SR/Trandolapril Study (INVEST).
    Cooper-DeHoff RM; Aranda JM; Gaxiola E; Cangiano JL; Garcia-Barreto D; Conti CR; Hewkin A; Pepine CJ;
    Am Heart J; 2006 May; 151(5):1072-9. PubMed ID: 16644338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying iatrogenic depression using confirmatory factor analysis of the Center for Epidemiologic Studies Depression Scale in patients prescribed a verapamil-sustained-release-led or atenolol-led hypertension treatment strategy.
    Wilson DL; Ried LD
    Res Social Adm Pharm; 2012; 8(4):309-20. PubMed ID: 22133650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Verapamil-sustained release-based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: an INternational VErapamil SR-Trandolapril (INVEST) substudy.
    Bangalore S; Messerli FH; Cohen JD; Bacher PH; Sleight P; Mancia G; Kowey P; Zhou Q; Champion A; Pepine CJ;
    Am Heart J; 2008 Aug; 156(2):241-7. PubMed ID: 18657652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of development of diabetes mellitus in patients with coronary artery disease taking antihypertensive medications (findings from the INternational VErapamil SR-Trandolapril STudy [INVEST]).
    Cooper-Dehoff R; Cohen JD; Bakris GL; Messerli FH; Erdine S; Hewkin AC; Kupfer S; Pepine CJ;
    Am J Cardiol; 2006 Oct; 98(7):890-4. PubMed ID: 16996868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulse pressure and risk of cardiovascular outcomes in patients with hypertension and coronary artery disease: an INternational VErapamil SR-trandolapril STudy (INVEST) analysis.
    Bangalore S; Messerli FH; Franklin SS; Mancia G; Champion A; Pepine CJ
    Eur Heart J; 2009 Jun; 30(11):1395-401. PubMed ID: 19351690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of adverse outcome among patients with hypertension and coronary artery disease.
    Pepine CJ; Kowey PR; Kupfer S; Kolloch RE; Benetos A; Mancia G; Coca A; Cooper-DeHoff RM; Handberg E; Gaxiola E; Sleight P; Conti CR; Hewkin AC; Tavazzi L;
    J Am Coll Cardiol; 2006 Feb; 47(3):547-51. PubMed ID: 16458134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. All you have to do is call; a pilot study to improve the outcomes of patients with coronary artery disease.
    Norris CM; Patterson L; Galbraith D; Hegadoren KM
    Appl Nurs Res; 2009 May; 22(2):133-7. PubMed ID: 19427576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity paradox in patients with hypertension and coronary artery disease.
    Uretsky S; Messerli FH; Bangalore S; Champion A; Cooper-Dehoff RM; Zhou Q; Pepine CJ
    Am J Med; 2007 Oct; 120(10):863-70. PubMed ID: 17904457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depression symptom severity and reported treatment history in the prediction of cardiac risk in women with suspected myocardial ischemia: The NHLBI-sponsored WISE study.
    Rutledge T; Reis SE; Olson MB; Owens J; Kelsey SF; Pepine CJ; Mankad S; Rogers WJ; Merz CN; Sopko G; Cornell CE; Sharaf B; Matthews KA; Vaccarino V
    Arch Gen Psychiatry; 2006 Aug; 63(8):874-80. PubMed ID: 16894063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcomes in the diabetes cohort of the INternational VErapamil SR-Trandolapril study.
    Bakris GL; Gaxiola E; Messerli FH; Mancia G; Erdine S; Cooper-DeHoff R; Pepine CJ;
    Hypertension; 2004 Nov; 44(5):637-42. PubMed ID: 15381674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy.
    Devereux RB; de Faire U; Fyhrquist F; Harris KE; Ibsen H; Kjeldsen SE; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H; Hille DA; Dahlöf B
    Curr Med Res Opin; 2007 Feb; 23(2):259-70. PubMed ID: 17288679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do recent life events and social support explain gender differences in depressive symptoms in patients who had percutaneous transluminal coronary angioplasty?
    Boutin-Foster C; Charlson ME
    J Womens Health (Larchmt); 2007; 16(1):114-23. PubMed ID: 17324102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of verapamil SR and atenolol on 24-hour blood pressure and heart rate in hypertension patients with coronary artery disease: an international verapamil SR-trandolapril ambulatory monitoring substudy.
    Denardo SJ; Gong Y; Cooper-DeHoff RM; Farsang C; Keltai M; Szirmai L; Messerli FH; Bavry AA; Handberg EM; Mancia G; Pepine CJ
    PLoS One; 2015; 10(4):e0122726. PubMed ID: 25835002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The quality of life related to depressive symptoms in coronary artery disease patients after successful coronary angioplasty: one-year follow up].
    Dudek D; Datka W; Iwek MS; Wróbel A; Zieba A
    Psychiatr Pol; 2007; 41(2):229-42. PubMed ID: 17598432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of atrial fibrillation in relation to changing heart rate over time in hypertensive patients: the LIFE study.
    Okin PM; Wachtell K; Kjeldsen SE; Julius S; Lindholm LH; Dahlöf B; Hille DA; Nieminen MS; Edelman JM; Devereux RB
    Circ Arrhythm Electrophysiol; 2008 Dec; 1(5):337-43. PubMed ID: 19808428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of changes in the electrocardiographic strain pattern during antihypertensive treatment: the Losartan Intervention for End-Point Reduction in Hypertension Study (LIFE).
    Okin PM; Oikarinen L; Viitasalo M; Toivonen L; Kjeldsen SE; Nieminen MS; Edelman JM; Dahlöf B; Devereux RB;
    Circulation; 2009 Apr; 119(14):1883-91. PubMed ID: 19332468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clustering of psychosocial risk factors enhances the risk of depressive symptoms 12-months post percutaneous coronary intervention.
    Pedersen SS; Denollet J; van Gestel YR; Serruys PW; van Domburg RT
    Eur J Cardiovasc Prev Rehabil; 2008 Apr; 15(2):203-9. PubMed ID: 18391649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indoleamine 2,3-dioxygenase activation and depressive symptoms in patients with coronary artery disease.
    Swardfager W; Herrmann N; Dowlati Y; Oh PI; Kiss A; Walker SE; Lanctôt KL
    Psychoneuroendocrinology; 2009 Nov; 34(10):1560-6. PubMed ID: 19540675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.